Physician profile
Cory A Collinge
NPI 1740214816
$2,837,792.68
in general payments reported to CMS, 2019-2025
23 companies · $944K in 2025
The $944K reported for 2025 was more than what 99% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $45K · 2021: $35K · 2022: $409K · 2023: $526K · 2024: $824K · 2025: $944K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $58K · Travel and Lodging: $16K · Food and Beverage: $3,024 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Entertainment: $23.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,215,093.91 |
| Consulting Fee | $57,950.56 |
| Travel and Lodging | $15,654.13 |
| Food and Beverage | $3,024.47 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Entertainment | $23.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $2,039,917.37 | 2022-2025 | Na |
| Zimmer Biomet Holdings, INC. | $522,795.54 | 2019-2025 | Affixus |
| Stryker Corporation | $89,357.00 | 2019-2025 | Pro, Axsos, Hoffmann |
| Arthrex, INC. | $63,600.94 | 2021-2022 | |
| Medical Device Business Services, INC. | $56,568.34 | 2019-2025 | Na, Tfn-Advance |
| Advanced Orthopaedic Solutions, INC. | $27,346.63 | 2019-2020 | |
| Smith+Nephew, INC. | $15,371.84 | 2019-2022 | |
| US Implant Solutions, LLC | $10,931.21 | 2023-2025 | |
| Synthes USA Products LLC | $7,267.80 | 2020 | |
| Synthes Gmbh | $2,795.90 | 2025 | |
| Depuy Synthes Sales INC. | $939.74 | 2019-2025 | Na, Expert Nail, Va-Lcp |
| Pylant Medical | $313.03 | 2024 | |
| Globus Medical, INC. | $135.36 | 2024 | Distal Femur Plate System |
| Medartis INC. | $124.36 | 2022 | |
| Integra Lifesciences Corporation | $101.10 | 2023 | Tenoglide |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $84.14 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $34.99 | 2019 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Horizon Therapeutics Plc | $29.37 | 2019 | |
| Argentum Medical | $23.93 | 2025 | |
| Polynovo North America LLC | $16.67 | 2023 | |
| Orthofix Medical, INC. | $7.42 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,270,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Collinge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.